<code id='4A06DD7CFA'></code><style id='4A06DD7CFA'></style>
    • <acronym id='4A06DD7CFA'></acronym>
      <center id='4A06DD7CFA'><center id='4A06DD7CFA'><tfoot id='4A06DD7CFA'></tfoot></center><abbr id='4A06DD7CFA'><dir id='4A06DD7CFA'><tfoot id='4A06DD7CFA'></tfoot><noframes id='4A06DD7CFA'>

    • <optgroup id='4A06DD7CFA'><strike id='4A06DD7CFA'><sup id='4A06DD7CFA'></sup></strike><code id='4A06DD7CFA'></code></optgroup>
        1. <b id='4A06DD7CFA'><label id='4A06DD7CFA'><select id='4A06DD7CFA'><dt id='4A06DD7CFA'><span id='4A06DD7CFA'></span></dt></select></label></b><u id='4A06DD7CFA'></u>
          <i id='4A06DD7CFA'><strike id='4A06DD7CFA'><tt id='4A06DD7CFA'><pre id='4A06DD7CFA'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:9436
          glum Benjamin — health insurance coverage from STAT
          Adobe

          Startup insurers Oscar Health, Bright Health, and Clover Health have hemorrhaged money since going public within the past two years. All three used their stage time at the J.P. Morgan Healthcare Conference to make the case that their drastic decisions — like fully exiting some insurance markets — will deliver the profitability investors are demanding.

          “Insurance company profitability is the number one goal,” Oscar CEO Mario Schlosser said in an interview with STAT in San Francisco.

          advertisement

          “We are actually absolutely focused on profitability right now,” Clover CEO Andrew Toy said during his presentation on Wednesday.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Eli Lilly to acquire Versanis in heated race for weight loss drugs
          Eli Lilly to acquire Versanis in heated race for weight loss drugs

          DarronCummings/APEliLillysaidFridayitwillacquireVersanisBio,aprivatecompanydevelopinganobesitydrugth

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Eli Lilly to acquire Versanis in heated race for weight loss drugs

          DarronCummings/APEliLillysaidFridayitwillacquireVersanisBio,aprivatecompanydevelopinganobesitydrugth